Published in J Dermatol Surg Oncol on November 01, 1993
20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters. Ann Surg Oncol (2011) 1.60
Campbell De Morgan's 'Observations on cancer', and their relevance today. J R Soc Med (2002) 1.44
Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer. Br J Cancer (2002) 0.90
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma. Ann Surg Oncol (2014) 0.85
The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies. BMC Cancer (2014) 0.76
The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options. Cancers (Basel) (2015) 0.75
Adjuvant therapy for melanoma: How should we respond to high-dose interferon? Br J Cancer (1998) 0.75
Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol (1992) 2.51
Update on the use of ciclosporin in immune-mediated dermatoses. Br J Dermatol (2006) 2.49
Treatment of pyoderma gangrenosum. J Am Acad Dermatol (1996) 2.21
Immunosuppressive agents in dermatology. An update. Dermatol Clin (1998) 1.53
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol (1989) 1.41
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol (1990) 1.33
Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res (1998) 1.18
Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice. Am J Pathol (1996) 1.13
Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol (1990) 1.02
Cutaneous manifestations of gastrointestinal disorders. Part I. J Am Acad Dermatol (1992) 0.99
Expression of cell cycle regulators in human cutaneous malignant melanoma. Melanoma Res (1999) 0.97
p53-dependent DNA repair and apoptosis respond differently to high- and low-dose ultraviolet radiation. Br J Dermatol (1998) 0.96
p53-regulated apoptosis is differentiation dependent in ultraviolet B-irradiated mouse keratinocytes. Am J Pathol (1998) 0.95
Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes. Am J Pathol (1997) 0.93
Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92. J Hematother (1999) 0.92
Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am J Pathol (1995) 0.92
Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice. Cancer Res (1995) 0.89
p53-dependent apoptosis in melanoma cells after treatment with camptothecin. J Invest Dermatol (2000) 0.87
Leukemic T cells from patients with cutaneous T-cell lymphoma demonstrate enhanced activation through CDw60, CD2, and CD28 relative to activation through the T-cell antigen receptor complex. J Invest Dermatol (1993) 0.85
p53-dependent regulation of nucleotide excision repair in murine epidermis in vivo. J Cutan Med Surg (1998) 0.85
Measurement of epidermal thickness in normal skin and psoriasis with high-frequency ultrasound. Skin Pharmacol (1988) 0.82
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. Br J Dermatol (2007) 0.81
Abnormal function of CD4+ helper/inducer T lymphocytes in a patient with widespread human papillomavirus type 3-related infection. Arch Dermatol (1990) 0.80
Cyclosporine therapy for severe atopic dermatitis. J Am Acad Dermatol (1989) 0.80
Penicillamine induced pemphigus. J Rheumatol (1985) 0.78
Effect of retinoic acid on apoptosis and DNA repair in human keratinocytes after UVB irradiation. J Cutan Med Surg (2000) 0.78
Effect of N-acetylcysteine on UVB-induced apoptosis and DNA repair in human and mouse keratinocytes. Photochem Photobiol (1999) 0.77
A putative marker for human melanoma. A monoclonal antibody derived from the melanoma gene in the Xiphophorus melanoma model. Am J Pathol (1993) 0.77
Effect of topical cyclosporine rinse on oral lichen planus. N Engl J Med (1991) 0.76
Graft-versus-host reaction affecting lesional skin but not normal skin in a patient with piebaldism. Br J Dermatol (1996) 0.76
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. Br J Dermatol (2005) 0.76
Common Skin Cancers: How to diagnose and treat them. Can Fam Physician (1992) 0.75
Malignant melanoma. Who shall live and who shall die? Arch Dermatol (1992) 0.75
Cyclosporine in the treatment of generalized granuloma annulare. J Am Acad Dermatol (1995) 0.75
Allergic contact dermatitis from rubber boots. Contact Dermatitis (1985) 0.75
Nickel dermatitis in infants. Contact Dermatitis (1986) 0.75
T-cell receptor variable region gene expression in cutaneous T-cell lymphomas. J Cutan Pathol (1992) 0.75
Ascomycins in dermatology. Semin Cutan Med Surg (1998) 0.75
Cyclic fever and rash in a 66-year-old woman. Chronic meningococcemia. Arch Dermatol (1992) 0.75